TrialNeuro-oncology2014

Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial.

Graziella Cefalo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.